PEOPLE - InMedica (US) makes appointment:
This article was originally published in Clinica
InMedica, the US company whose MicroCor subsidiary is developing a fast and non-invasive test for measuring hematocrit using electrical impedence, has appointed Ralph Henson president and CEO. Larry Clark, who has been president of the company for the last three years, will remain as chairman. Mr Henson joins from In-Line Diagnostics.
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.